Works matching IS 22965270 AND DT 2016 AND VI 39 AND IP 9
Results: 25
Neue Therapieoption für vorbehandelte Patienten.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 9, p. 567
- Publication type:
- Article
Cabozantinib erhält Zulassungsempfehlung des CHMP zur Behandlung des fortgeschrittenen Nierenzellkarzinoms.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 9, p. 567
- By:
- Publication type:
- Article
Zulassung für Obinutuzumab zur Therapie von Patienten mit vorbehandeltem follikulärem Lymphom.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 9, p. 567
- By:
- Publication type:
- Article
Supportive Ernährungstherapie - Stellenwert der medizinischen Trinknahrung bei Tumorpatienten.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 9, p. 567
- By:
- Publication type:
- Article
Zytiga® in der Erstlinie mit frühem Beginn.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 9, p. 567
- By:
- Publication type:
- Article
Kyprolis® erhält Indikationserweiterung für die Behandlung von Patienten mit rezidiviertem oder refraktärem multiplem Myelom.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 9, p. 567
- By:
- Publication type:
- Article
ASCO 2016: Aktuelle Subgruppenanalyse der Phase-III-Studie REVEL - Fortgeschrittenes nichtkleinzelliges Lungenkarzinom.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 9, p. 567
- Publication type:
- Article
Internationale Kongress-Highlights 2016 zu Nilotinib und Ruxolitinib, ein wissenschaftliches Update.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 9, p. 567
- By:
- Publication type:
- Article
Metastasiertes Nierenzellkarzinom (mRCC) Zehn Jahre zielgerichtete Therapie mit Sunitinib: auch in Zukunft auf Erfahrung bauen.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 9, p. 567
- Publication type:
- Article
Phase-Ib-Studie zu Ribociclib (LEE011) plus Letrozol bei fortgeschrittenem Brustkrebs.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 9, p. 567
- By:
- Publication type:
- Article
Europäische Kommission erteilt Zulassung für Elotuzumab (Empliciti®) in Kombination mit Lenalidomid und Dexamethason.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 9, p. 567
- Publication type:
- Article
Neue Erstlinientherapie für CLL-Patienten.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 9, p. 567
- Publication type:
- Article
Zehn Jahre Immuntherapie bei Kopf-Hals-Tumoren - etablierte Standards und neue Rahmenbedingungen.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 9, p. 567
- By:
- Publication type:
- Article
Reports of Oncological Societies.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 9, p. 560, doi. 10.1159/000448982
- Publication type:
- Article
Therapierelevante Daten zu gastrointestinalen Tumoren beim ASCO 2016.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 9, p. 557, doi. 10.1159/000448643
- By:
- Publication type:
- Article
Ongoing Clinical Trials in Testicular Cancer: The TIGER Trial.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 9, p. 553, doi. 10.1159/000448868
- Publication type:
- Article
Multitargeted Kinase Inhibition in Metastatic Differentiated Radioiodine-Refractory Thyroid Cancer: A Look at New Therapeutic Options for a Rare Disease.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 9, p. 548, doi. 10.1159/000448387
- By:
- Publication type:
- Article
Necitumumab plus Gemcitabine and Cisplatin as First-Line Therapy in Patients with Stage IV EGFR-Expressing Squamous Non-Small-Cell Lung Cancer: German Subgroup Data from an Open-Label, Randomized Controlled Phase 3 Study (SQUIRE).
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 9, p. 539, doi. 10.1159/000448085
- By:
- Publication type:
- Article
Association of the MTHFR Gene C677T Polymorphism with Breast Cancer in a Turkish Population.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 9, p. 534, doi. 10.1159/000448084
- By:
- Publication type:
- Article
State-of-the-Art Treatment and Novel Agents in Local and Distant Recurrences of Cervical Cancer.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 9, p. 525, doi. 10.1159/000448529
- By:
- Publication type:
- Article
Neoadjuvant and Adjuvant Chemotherapy of Cervical Cancer.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 9, p. 522, doi. 10.1159/000449023
- By:
- Publication type:
- Article
Radiotherapy of Cervical Cancer.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 9, p. 516, doi. 10.1159/000448902
- By:
- Publication type:
- Article
Surgical Treatment of Early-Stage Cervical Cancer.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 9, p. 508, doi. 10.1159/000448794
- By:
- Publication type:
- Article
Epidemiology and Early Detection of Cervical Cancer.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 9, p. 501, doi. 10.1159/000448385
- By:
- Publication type:
- Article
A Change of Paradigm in the Treatment of Cervical Cancer.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 9, p. 500, doi. 10.1159/000448967
- By:
- Publication type:
- Article